Jinxin Fertility Group Limited (JXR) has filed a Next Day Disclosure Return with the Hong Kong Stock Exchange detailing its latest share buy-back activity and current share capital position as of 21 April 2026. The company’s total issued share count remains unchanged at 2.71 billion ordinary shares, with no treasury shares on hand.

On 21 April 2026 JXR repurchased 0.80 million shares on-market at prices ranging from HKD 2.45 to HKD 2.47, spending HKD 1.97 million in aggregate. All of these shares are intended for cancellation.

Including this transaction, shares bought back but not yet cancelled since 27 March 2026 total 15.60 million, equivalent to approximately 0.58% of JXR’s outstanding shares prior to the repurchase series. The weighted-average prices for the earlier tranches ranged between HKD 2.29 and HKD 2.47 per share.

Under the general mandate approved on 26 June 2025, JXR is authorised to repurchase up to 274.47 million shares. Cumulative repurchases under this mandate have reached 55.26 million shares, representing 2.01% of the company’s share base on the mandate date. In line with Hong Kong listing rules, JXR is subject to a moratorium on issuing new shares until 21 May 2026 following the latest buyback.

The company confirmed that all repurchases were executed in accordance with Hong Kong Stock Exchange requirements and the terms set out in its explanatory statement dated 4 June 2025.